1. Stocks
  2. Xeris Biopharma Holdings Inc
  3. Swot
swot-logo

Xeris Biopharma Holdings Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Xeris Biopharma Holdings Inc has 20 Strengths, 3 Weaknesses, 5 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

30 Day SMA crossing over 200 Day SMA, and current price greater than open

High Normalized Momentum Score

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

Relative Outperformance versus Industry over 1 Year

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Increasing Revenue every Quarter for the past 4 Quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Top Gainers

Stock with Low PE (PE < = 10)

RSI indicating price strength

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Mutual Funds Increased Shareholding in Past Month

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Promoters increasing shareholding QoQ